Professor Fred Ledley is a physician by training, and his professional career has taken him from basic research in molecular biology, to founding and executive roles in several biotechnology companies, and now to Bentley. Along the way, he has published more than 150 papers in the academic literature and received ten US patents. His research builds on this experience in asking whether recent scientific discoveries are being effectively translated into public value, and how this process might be accelerated.